Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,083,858 | 1,588,691 | 1,770,701 | 1,400,849 | 1,404,008 |
| Marketable Securities | 1,934,792 | 2,046,861 | 1,766,090 | 1,760,230 | 1,814,508 |
| Receivables | 793,072 | 703,325 | 531,297 | 857,105 | 669,870 |
| Inventories | 10,220 | 7,451 | N/A | N/A | N/A |
| Other current assets | 0 | 1 | -1 | -1 | 1 |
| TOTAL | $4,821,942 | $4,346,329 | $4,068,087 | $4,018,183 | $3,888,387 |
| Non-Current Assets | |||||
| PPE Net | 137,678 | 132,659 | 123,350 | 113,138 | 100,257 |
| Investments And Advances | 22,776 | 26,736 | 20,174 | 18,833 | 20,972 |
| Intangibles | 16,790 | 18,847 | 19,021 | 20,674 | 27,060 |
| Other Non-Current Assets | 145,562 | 147,415 | 149,144 | 116,537 | 115,140 |
| TOTAL | $322,806 | $325,657 | $311,688 | $269,182 | $263,429 |
| Total Assets | $5,144,748 | $4,671,986 | $4,379,775 | $4,287,365 | $4,151,816 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 341,786 | 274,376 | 264,135 | 242,986 | 260,047 |
| Other current liabilities | N/A | N/A | N/A | N/A | 812 |
| TOTAL | $423,692 | $291,177 | $281,716 | $258,137 | $404,276 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,818 | 4,821 | 4,755 | 4,673 | 4,465 |
| Other Non-Current Liabilities | 108,624 | 109,575 | 110,813 | 75,614 | 75,903 |
| TOTAL | $178,704 | $179,703 | $179,981 | $143,582 | $140,847 |
| Total Liabilities | $602,396 | $470,880 | $461,696 | $401,719 | $545,124 |
| Shareholders' Equity | |||||
| Common Shares | 9,636 | 9,643 | 9,511 | 9,346 | 8,930 |
| Retained earnings | 2,693,992 | 2,361,707 | 2,113,371 | 2,119,469 | 1,934,655 |
| Other shareholders' equity | 20,732 | 16,362 | 16,859 | 13,877 | 20,430 |
| TOTAL | $4,542,352 | $4,201,105 | $3,918,079 | $3,885,646 | $3,606,692 |
| Total Liabilities And Equity | $5,144,748 | $4,671,985 | $4,379,775 | $4,287,365 | $4,151,816 |